Ganaxolone Safety Profile in CDKL5 Deficiency Disorder: Results From a Phase 3 Randomized, Double-blind, Placebo-Controlled Trial

被引：0
|
作者：
Pestana-Knight, E.
Rybak, E.
Grachev, I
Miller, I
机构：
来源：
ANNALS OF NEUROLOGY | 2021年 / 90卷
关键词：
Epilepsy;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
244
引用
收藏
页码：S132 / S133
页数：2
相关论文
共 50 条
  • [21] Efficacy and Safety of Tocilizumab in Patients with Refractory Takayasu Arteritis: Results from a Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial in Japan
    Nakaoka, Yoshikazu
    Isobe, Mitsuaki
    Takei, Syuji
    Tanaka, Yoshiya
    Ishii, Tomonori
    Yokota, Shumpei
    Nomura, Akira
    Yoshida, Seitaro
    Nishimoto, Norihiro
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [22] Lamotrigine Therapy for Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
    Karin M. Belsito
    Paul A. Law
    Karen S. Kirk
    Rebecca J. Landa
    Andrew W. Zimmerman
    Journal of Autism and Developmental Disorders, 2001, 31 : 175 - 181
  • [23] Lamotrigine therapy for autistic disorder: A randomized, double-blind, placebo-controlled trial
    Belsito, KM
    Law, PA
    Kirk, KS
    Landa, RJ
    Zimmerman, AW
    JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2001, 31 (02) : 175 - 181
  • [24] Escitalopram in the treatment of panic disorder: A randomized, double-blind, placebo-controlled trial
    Stahl, SM
    Gergel, I
    Li, DY
    JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (11) : 1322 - 1327
  • [25] Safety and Tolerability of Dexpramipexole for the Treatment of ALS: Results from the Randomized, Double-Blind, Placebo-Controlled Trial, EMPOWER
    Van den Berg, Leonard
    Cudkowicz, Merit
    Shefner, Jeremy
    Mitsumoto, Hiroshi
    Mora, Jesus
    Ludolph, Albert
    Hardiman, Orla
    Ingersoll, Evan
    Archibald, Donald
    Li, Xiaoxi
    Dong, Yingwen
    Kerr, Douglas
    Farwell, Wildon
    NEUROLOGY, 2013, 80
  • [26] Efficacy and safety of prucalopride in men with chronic constipation: a phase 3, randomized, double-blind, placebo-controlled trial
    Yiannakou, Yan
    Bouchoucha, Michel
    Schiefke, Ingolf
    Piessevaux, Hubert
    Filip, Rafal
    Stephenson, David
    Green, Alexandra
    Levine, Amy
    GASTROENTEROLOGY, 2014, 146 (05) : S160 - S160
  • [27] Efficacy and Safety of Sublingual Cyclobenzaprine for the Treatment of Fibromyalgia: Results From a Randomized, Double-Blind, Placebo-Controlled Trial
    Lederman, Seth
    Arnold, Lesley M.
    Vaughn, Ben
    Kelley, Mary
    Sullivan, Gregory M.
    ARTHRITIS CARE & RESEARCH, 2023, 75 (11) : 2359 - 2368
  • [28] Efficacy and Safety of Golimumab in Patients With Ankylosing Spondylitis Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
    Inman, Robert D.
    Davis, John C., Jr.
    van der Heijde, Desiree
    Dickman, Laura
    Sieper, Joachim
    Kim, Sung Il
    Mack, Michael
    Han, John
    Visvanathan, Sudha
    Xu, Zhenhua
    Su, Benjamin
    Beutler, Anna
    Braun, Juergen
    ARTHRITIS AND RHEUMATISM, 2008, 58 (11): : 3402 - 3412
  • [29] SAFETY OF AMISELIMOD IN HEALTHY SUBJECTS: RESULTS FROM A PHASE 1 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Hanauer, Stephen
    O'Reilly, Terry
    Lester, Robert
    Slatkin, Neal
    Lee, Jimin
    Franklin, Howard
    Bulawski, Angela
    Israel, Robert
    GASTROENTEROLOGY, 2021, 160 (03) : S1 - S2
  • [30] SAFETY OF AMISELIMOD IN HEALTHY SUBJECTS: RESULTS FROM A PHASE 1 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Hanauer, Stephen
    O'Reilly, Terry
    Lester, Robert
    Slatkin, Neal
    Lee, Jimin
    Franklin, Howard
    Bulawski, Angela
    Israel, Robert
    INFLAMMATORY BOWEL DISEASES, 2021, 27 : S1 - S1
12345